ClinicalTrials.Veeva

Menu

Two- Dimensional Speckle Tracking Echocardiography After Primary Percutaneous Coronary Intervention

A

Assiut University

Status

Unknown

Conditions

Myocardial Infarction

Treatments

Procedure: 2D speckle tracking echocardiography

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

ST-segment elevation myocardial infarction (STEMI) is a major cause of morbidity and mortality worldwide. In spite of decrease in acute and long-term mortality following STEMI in parallel with more use of reperfusion therapy, such as primary percutaneous coronary intervention (PPCI), modern antithrombotic therapy, and secondary prevention, mortality remains considerable. Reduced EF is a well-known predictor of increased short and long term major adverse cardiovascular events MACE :( heart failure, stroke and death)

Enrollment

204 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ST elevation myocardial infarction patients after primary percutaneous coronary intervention

Exclusion criteria

  • Previous myocardial infarction.
  • Sever or haemodynamically significant (associated with chamber dilation) valvular heart diseases.
  • Previous heart failure.
  • Previous cerebrovascular strokes.
  • Atrial fibrillation.
  • Severe comorbidities as severe renal impairment, hepatic or respiratory failure.
  • Bad equality views which affects accurate speckle tracking imaging.

Trial design

204 participants in 1 patient group

Study group
Description:
ST elevation myocardial infarction (STEMI) patients after primary percutaneous coronary intervention who will be followed up in Assiut University hospital.
Treatment:
Procedure: 2D speckle tracking echocardiography

Trial contacts and locations

0

Loading...

Central trial contact

Aly Tohamy, MD; Ayman Khairy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems